Prospects and Challenges of Translational Corneal Bioprinting

Corneal transplantation remains the ultimate treatment option for advanced stromal and endothelial disorders. Corneal tissue engineering has gained increasing interest in recent years, as it can bypass many complications of conventional corneal transplantation. The human cornea is an ideal organ for...

Full description

Bibliographic Details
Main Authors: Matthias Fuest, Gary Hin-Fai Yam, Jodhbir S. Mehta, Daniela F. Duarte Campos
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Bioengineering
Subjects:
3D
Online Access:https://www.mdpi.com/2306-5354/7/3/71
id doaj-b11a8c08a7334de9991457bff8ad6a55
record_format Article
spelling doaj-b11a8c08a7334de9991457bff8ad6a552020-11-25T02:57:45ZengMDPI AGBioengineering2306-53542020-07-017717110.3390/bioengineering7030071Prospects and Challenges of Translational Corneal BioprintingMatthias Fuest0Gary Hin-Fai Yam1Jodhbir S. Mehta2Daniela F. Duarte Campos3Department of Ophthalmology, RWTH Aachen University, 52074 Aachen, GermanyDepartment of Ophthalmology, University of Pittsburgh, Pittsburgh, PA 15260, USATissue Engineering and Stem Cell Group, Singapore Eye Research Institute, Singapore 169856, SingaporeInstitute of Applied Medical Engineering, RWTH Aachen University, 52074 Aachen, GermanyCorneal transplantation remains the ultimate treatment option for advanced stromal and endothelial disorders. Corneal tissue engineering has gained increasing interest in recent years, as it can bypass many complications of conventional corneal transplantation. The human cornea is an ideal organ for tissue engineering, as it is avascular and immune-privileged. Mimicking the complex mechanical properties, the surface curvature, and stromal cytoarchitecure of the in vivo corneal tissue remains a great challenge for tissue engineering approaches. For this reason, automated biofabrication strategies, such as bioprinting, may offer additional spatial control during the manufacturing process to generate full-thickness cell-laden 3D corneal constructs. In this review, we discuss recent advances in bioprinting and biomaterials used for in vitro and ex vivo corneal tissue engineering, corneal cell-biomaterial interactions after bioprinting, and future directions of corneal bioprinting aiming at engineering a full-thickness human cornea in the lab.https://www.mdpi.com/2306-5354/7/3/71bioprintingcorneal tissue engineeringhydrogelcell-biomaterial interaction3D
collection DOAJ
language English
format Article
sources DOAJ
author Matthias Fuest
Gary Hin-Fai Yam
Jodhbir S. Mehta
Daniela F. Duarte Campos
spellingShingle Matthias Fuest
Gary Hin-Fai Yam
Jodhbir S. Mehta
Daniela F. Duarte Campos
Prospects and Challenges of Translational Corneal Bioprinting
Bioengineering
bioprinting
corneal tissue engineering
hydrogel
cell-biomaterial interaction
3D
author_facet Matthias Fuest
Gary Hin-Fai Yam
Jodhbir S. Mehta
Daniela F. Duarte Campos
author_sort Matthias Fuest
title Prospects and Challenges of Translational Corneal Bioprinting
title_short Prospects and Challenges of Translational Corneal Bioprinting
title_full Prospects and Challenges of Translational Corneal Bioprinting
title_fullStr Prospects and Challenges of Translational Corneal Bioprinting
title_full_unstemmed Prospects and Challenges of Translational Corneal Bioprinting
title_sort prospects and challenges of translational corneal bioprinting
publisher MDPI AG
series Bioengineering
issn 2306-5354
publishDate 2020-07-01
description Corneal transplantation remains the ultimate treatment option for advanced stromal and endothelial disorders. Corneal tissue engineering has gained increasing interest in recent years, as it can bypass many complications of conventional corneal transplantation. The human cornea is an ideal organ for tissue engineering, as it is avascular and immune-privileged. Mimicking the complex mechanical properties, the surface curvature, and stromal cytoarchitecure of the in vivo corneal tissue remains a great challenge for tissue engineering approaches. For this reason, automated biofabrication strategies, such as bioprinting, may offer additional spatial control during the manufacturing process to generate full-thickness cell-laden 3D corneal constructs. In this review, we discuss recent advances in bioprinting and biomaterials used for in vitro and ex vivo corneal tissue engineering, corneal cell-biomaterial interactions after bioprinting, and future directions of corneal bioprinting aiming at engineering a full-thickness human cornea in the lab.
topic bioprinting
corneal tissue engineering
hydrogel
cell-biomaterial interaction
3D
url https://www.mdpi.com/2306-5354/7/3/71
work_keys_str_mv AT matthiasfuest prospectsandchallengesoftranslationalcornealbioprinting
AT garyhinfaiyam prospectsandchallengesoftranslationalcornealbioprinting
AT jodhbirsmehta prospectsandchallengesoftranslationalcornealbioprinting
AT danielafduartecampos prospectsandchallengesoftranslationalcornealbioprinting
_version_ 1724709468017524736